Differential release of acetylcholinesterase in vivo, from the guinea pig substantia nigra compared to the caudate putamen following dopamine depletion

Neuropharmacology

Volumn 35, Issue 5, 1996, Pages 579-587

  Dally, Jonathan J ^a   Temlett, James A ^b   Greenfield, Susan A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Acetylcholinesterase; Caudate putamen; Chemiluminescence; Dopamine; Neurotoxins; Substantia nigra

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACETYLCHOLINESTERASE; DOPAMINE; NEUROTOXIN; OXIDOPAMINE; POTASSIUM ION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN INJURY; BRAIN REGION; CAUDATE NUCLEUS; CHEMOLUMINESCENCE; CONTROLLED STUDY; DEPLETION; DOPAMINERGIC NERVE CELL; ENZYME RELEASE; GUINEA PIG; HISTOLOGY; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA; TISSUE LEVEL;

EID: 0030152082     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(96)84627-2     Document Type: Article

References (45)

1. Anton A.H., Sayre D.F. A study of the factors affecting aluminium oxide-trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther. 138:1962;360-375.
2. Birman S. Determination of acetylcholinesterase activity by a new chemiluminescence assay with the natural substrate. Biochem J. 225(3):1985;825-828.
3. Butcher L.L., Woolf N.J. Monoaminergic-cholinergic relationships and the chemical communication matrix of the substantia nigra and neostriatum. Brain Res. Bull. 9:1982;475-492.
4. Chiueh C.C., Markey S.P., Burns R.S., Johannessen J.N., Jacobowitz D.M., Kopin I.J. Neurochemical and behavioural effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rat, guinea pig and monkey. Psychopharm. Bull. 20(3):1984;548-553.
5. Chubb I.W., Bornstein J.C. Dopamine and acetylcholinesterase released in the substantia nigra: cooperative or coincidental? Neurochem. Int. 7(6):1985;905-912.
6. Dally J.J., Greenfield S.A. The release of acetylcholinesterase in vivo is regulated by dopaminergic systems in the guinea pig substantia nigra. Neurochem. Int. 25(4):1994;339-344.
7. Ellman G.L., Courtney K.D., Andres V., Featersone K.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
8. Engel A.K., Kreutzberg G.W. Changes of acetylcholinesterase molecular forms in regenerating motor neurons. Neuroscience. 18(2):1986;467-473.
9. Greenfield S.A. Acetylcholinesterase may have novel functions in the brain. Trends Neurosci. 7(10):1984;364-368.
10. Greenfield S.A. The significance of dendritic release of transmitter and protein in the substantia nigra. Neurochem. Int. 7(6):1985;887-901.
11. Greenfield S.A. A non-cholinergic action of acetylcholinesterase (AChE) in the brain: from neuronal secretion to the generation of movement. Molec. Cell. Neurobiol. 11(1):1991;55-77.
12. Greenfield S.A., Smith A.D. The influence of electrical stimulation of certain brain areas on the concentration of acetylcholinesterase in rabbit cerebrospinal fluid. Brain Res. 177:1979;445-459.
13. Greenfield S.A., Shaw S.G. Release of acetylcholinesterase and aminopeptidase in vivo following infusion of amphetamine into the substantia nigra. Neuroscience. 7:1982;2883-2893.
14. Greenfield S.A., Cheramy A., Glowinski J. In vivo release of acetylcholinesterase in cat substantia nigra and caudate nuclei. Nature. 284:1980;355-357.
15. Greenfield S.A., Grunewald R.A., Foley P., Shaw S.G. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigrostriatal pathway. J. Comp. Neurol. 214:1983;87-92.
16. Greenfield S.A., Appleyard M.E., Bloomfield M.R. 6-Hydroxydopamine-induced turning behaviour in the rat: the significance of acetylcholinesterase in cerebrospinal fluid. Behav. Brain Res. 21:1986;47-54.
17. Gregory E.J., Hodges-Savola C.A., Fernandez H.L. Selective increase of tetrameric (G4) acetylcholinesterase activity in rat hindlimb skeletal muscle following short-term denervation. J. Neurochem. 53:1989;1411-1418.
18. Henderson Z., Greenfield S.A. Ultrastructural localisation of acetylcholinesterase in substantia nigra: a comparison between rat and guinea pig. J. Comp. Neurol. 230:1984;278-286.
19. Hornykiewicz O. (1993) Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. In Advances in Neurology, Vol. 60 (Narabayashi H., Nagatsu T., Yanagisawa N. and Mizuno Y., Eds.), pp. 140-147. Raven Press, New York.
20. Israel M., Lesbats B. Chemiluminescent determination of acetylcholine, and continuous detection of its release from Torpedo electric organ synapses and synaptosomes. Neurochem. Int. 3:1981;81-90.
21. Jones S.A., Greenfield S.A. Behavioural correlates of the release and subsequent action of acetylcholinesterase secreted in the substantia nigra. Eur. J. Neurosci. 3:1991;292-295.
22. Jones S.A., Holmes C., Budd T.C., Greenfield S.A. The effect of acetylcholinesterase on outgrowth of dopaminergic neurons in organotypic slice culture of the rat brain. Cell Tissue Res. 279:1995;323-330.
23. Kaakkola S., Teräväinen H. Animal models of Parkinsonism. Pharmacol. Toxicol. 67:1990;95-100.
24. Langston J.W. MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci. 36(3):1985;201-206.
25. Lin J.-Y., Mai L.-M., Pan J.-T. Effects of systemic administration of 6-hydroxydopamine, 6-hydroxydopa and 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on tuberoinfundibular dopaminergic neurons in the rat. Brain Res. 624:1993;126-130.
26. Liu J., Mori L. Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free-radical induced damage. Arch. Biochem. Biophys. 284:1980;355-357.
27. Llinás R.R., Greenfield S.A. On-line visualization of dendritic release of acetylcholinesterase from mammalian substantia nigra neurons. Proc. Natn. Acad. Sci. U.S.A. 84:1987;3047-3050.
28. Llinás R.R., Greenfield S.A., Jahnsen H. Electrophysiology of pars compacta cells in the in vitro substantia nigra - a possible mechanism for dendritic release. Brain Res. 294:1984;127-132.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randell R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
30. MacDonald E. and Sirviö J. (1993) Neurotoxins as tools in lesioning experiments. In Natural and Synthetic Neurotoxins (Harvey A.L., Ed.), pp. 1-46. Academic Press, London.
31. Marsden C.D. Parkinson's disease. Lancet. 335:1990;948-952.
32. Maruyama W., Naoi M. Inhibition of tyrosine hydroxylase by a dopamine neurotoxin, 1-methyl-4-phenyl-pyridinium ion: depletion of allostery to the biopterin cofactor. Life Sci. 53(3):1994;207-212.
33. Perry T.L., Yong V.W., Ito M., Jones K., Wall R.A., Foulks J.G., Wright J.M., Kish S.J. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig. Life Sci. 36:1985;1233-1238.
34. Rapisarda C., Bacchelli B. The brain of the guinea pig in stereotaxic co-ordinates. Arch. Sci. Biol. 61:1977;1-37.
35. Reuberg M., Rieger F., Villageois A., Bonnet A.M., Agid Y. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease. Brain Res. 362:1986;83-91.
36. Rinne U.K., Riekkinen P., Sonninen V., Laaksonen H. Brain acetylcholinesterase in Parkinson's disease. Acta Neurol. Scandinav. 49:1973;215-226.
37. Robertson R.T., Tijerina A.A., Gallivan M.E. Transient patterns of acetylcholinesterase activity in the visual cortex of the rat: normal development and the effects of neonatal monocular enucleation. Dev. Brain Res. 21:1985;203-214.
38. Robertson R.T., Hanes M.A., Yu J. Investigations of the origins of transient acetylcholinesterase activity in developing rat visual cortex. Dev. Brain Res. 41:1988;1-23.
39. Santiago M., Machado A., Cano J. Fast sodium channel dependency of the somatodendritic release of dopamine in the rat's brain. Neurosci. Lett. 148:1992;145-147.
40. Sirinathsinghji D.J.S., Whittington P.E., Audsley A.R. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Brain Res. 399:1986;339-345.
41. Taylor S.J., Haggblad J., Greenfield S.A. Measurement of cholinesterase activity released from the brain "on-line" and in vivo. Neurochem. Int. 15(2):1989;199-205.
42. Taylor S.J., Jones S.A., Haggblad J., Greenfield S.A. "On-line" measurement of acetylcholinesterase release from the substantia nigra of the freely-moving guinea pig. Neuroscience. 37(1):1990;71-76.
43. Tipton K.F., Singer T.P. Advances in our understanding of mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61(4):1993;1191-1206.
44. Weston J., Greenfield S.A. Release of acetylcholinesterase in the rat nigrostriatal pathway: relation to receptor activation and firing rate. Neuroscience. 17:1986;1079-1088.
45. Zang L.-Y., Misra H.P. Acetylcholinesterase inhibition by 1-methyl-4-phenylpyridinium ion, a bioactivated metabolite of MPTP. Molec. Cell. Biochem. 126(2):1993;93-100.